Vaccitech Contact Us
A prized UK biotech firm looks to Wall Street, much to Rishi …
WebApr 8, 2021 · Vaccitech, the Oxford-based firm that owns some of the key biotechnology behind the AstraZeneca Covid vaccine, is off to New York for a public listing. One can …
See Also: Tech Support Preview / Show details
Vaccitech acquires Avidea Technologies to expand product …
WebDec 14, 2021 · Vaccitech co-invented a COVID-19 vaccine with the University of Oxford, now approved for use in many territories and exclusively licensed worldwide to AstraZeneca through Oxford University Innovation, or OUI. Vaccitech is entitled to receive a share of the milestones and royalty income received by OUI from AstraZeneca. About Avidea …
See Also: Tech Support Preview / Show details
Vaccitech acquires Avidea Technologies to expand product
WebDec 14, 2021 · Vaccitech co-invented a COVID-19 vaccine with the University of Oxford, now approved for use in many territories and exclusively licensed worldwide to …
See Also: Tech Support Preview / Show details
Biotech startup Vaccitech confidentially files for U.S. IPO: FT
WebApr 7, 2021 · By Reuters Staff 2 Min Read (Reuters) - Biotech startup Vaccitech, which owns the technology behind the COVID-19 vaccine developed by Oxford and …
See Also: Tech Support Preview / Show details
Vaccitech slides in US stock market debut Financial Times
WebApr 30, 2021 · The company’s shares started trading at $13.62 on the Nasdaq, almost 20 per cent lower than the offer price Vaccitech set on Thursday. The biotech company …
See Also: Tech Support Preview / Show details
Vaccitech plc (VACC) Stock Price, News, Quote & History Yahoo …
WebOXFORD, United Kingdom, June 12, 2023 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC) (the Company, we or us), a clinical-stage biopharmaceutical …
See Also: Tech Support Preview / Show details